fosaprepitant

Generic: fosaprepitant

Labeler: actavis pharma, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name fosaprepitant
Generic Name fosaprepitant
Labeler actavis pharma, inc.
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

fosaprepitant dimeglumine 150 mg/1

Manufacturer
Actavis Pharma, Inc.

Identifiers & Regulatory

Product NDC 0591-4385
Product ID 0591-4385_89783971-3346-4ff8-ac47-d824a7ddf75d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA210064
Listing Expiration 2026-12-31
Marketing Start 2019-09-19

Pharmacologic Class

Classes
cytochrome p450 2c9 inducers [moa] cytochrome p450 3a4 inducers [moa] cytochrome p450 3a4 inhibitors [moa] neurokinin 1 antagonists [moa] substance p/neurokinin-1 receptor antagonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 05914385
Hyphenated Format 0591-4385

Supplemental Identifiers

RxCUI
1731077
UPC
0305914385794
UNII
D35FM8T64X

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name fosaprepitant (source: ndc)
Generic Name fosaprepitant (source: ndc)
Application Number NDA210064 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0591-4385-79)
source: ndc

Packages (1)

0591-4385-79 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0591-4385-79)

Ingredients (1)

fosaprepitant dimeglumine (150 mg/1)

Linked Drug Pages (1)

Fosaprepitant ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "89783971-3346-4ff8-ac47-d824a7ddf75d", "openfda": {"upc": ["0305914385794"], "unii": ["D35FM8T64X"], "rxcui": ["1731077"], "spl_set_id": ["9dbd4c29-d894-4839-9b22-a2f65c8c8ad1"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0591-4385-79)", "package_ndc": "0591-4385-79", "marketing_start_date": "20190919"}], "brand_name": "Fosaprepitant", "product_id": "0591-4385_89783971-3346-4ff8-ac47-d824a7ddf75d", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "0591-4385", "generic_name": "fosaprepitant", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fosaprepitant", "active_ingredients": [{"name": "FOSAPREPITANT DIMEGLUMINE", "strength": "150 mg/1"}], "application_number": "NDA210064", "marketing_category": "NDA", "marketing_start_date": "20190919", "listing_expiration_date": "20261231"}